Page last updated: 2024-11-05

brilliant orange 3r

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

brilliant orange 3R: RN given refers to di-Na salt; RN for parent cpd not avail 11/92; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID30082
CHEBI ID53730
SCHEMBL ID523942
SCHEMBL ID524600
SCHEMBL ID20483012
MeSH IDM0207302

Synonyms (32)

Synonym
brilliant orange 3r
20262-58-2
reactive orange 16
reactive orange 16, dye content >=70 %
remazol orange g
disodium 6-acetamido-4-hydroxy-3-[(4-{[2-(sulfonatooxy)ethyl]sulfonyl}phenyl)diazenyl]naphthalene-2-sulfonate
remazol brilliant orange 3r
CHEBI:53730 ,
einecs 243-653-9
2-naphthalenesulfonic acid, 6-(acetylamino)-4-hydroxy-3-(2-(4-((2-(sulfooxy)ethyl)sulfonyl)phenyl)diazenyl)-, sodium salt (1:2)
2-naphthalenesulfonic acid, 6-(acetylamino)-4-hydroxy-3-((4-((2-(sulfooxy)ethyl)sulfonyl)phenyl)azo)-, disodium salt
ec 243-653-9
disodium 6-acetamido-4-hydroxy-3-((4-((2-(sulphonatooxy)ethyl)sulphonyl)phenyl)azo)naphthalene-2-sulphonate
EPITOPE ID:116217
2-naphthalenesulfonic acid, 6-(acetylamino)-4-hydroxy-3-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-, disodium salt
BP-20531
SCHEMBL523942
SCHEMBL524600
DTXSID5066586
reactive orange 7
W-110515
disodium 6-acetamido-4-hydroxy-3-[[4-[[2-(sulphonatooxy)ethyl]sulphonyl]phenyl]azo]naphthalene-2-sulphonate
mfcd00013281
J-004776
12225-88-6
SCHEMBL20483012
2-naphthalenesulfonic acid, 6-(acetylamino)-4-hydroxy-3-[2-[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-, sodium salt
AS-17191
6-acetamido-4-hydroxy-3-4-2-(sulphonatooxy)ethylsulphonylphenylazonaphthalene-2-sulphonate (sodium salt)
disodium;6-acetamido-4-hydroxy-3-[[4-(2-sulfonatooxyethylsulfonyl)phenyl]diazenyl]naphthalene-2-sulfonate
AKOS037643596
disodium;(3z)-6-acetamido-4-oxo-3-[[4-(2-sulfonatooxyethylsulfonyl)phenyl]hydrazinylidene]naphthalene-2-sulfonate

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" DB3 dye was the most toxic of all dyes in the bacterial, algal and protozoan tests."( Comparative use of bacterial, algal and protozoan tests to study toxicity of azo- and anthraquinone dyes.
Dias, N; Itävaara, M; Kapanen, A; Lima, N; Malachová, K; Novotný, C; Vándrovcová, M, 2006
)
0.33
" Toxicity studies confirmed the genotoxic, cytotoxic, and phytotoxic nature of RO16 and the formation of less toxic products after the treatment of Lysinibacillus sp."( Oxidative stress response in dye degrading bacterium Lysinibacillus sp. RGS exposed to Reactive Orange 16, degradation of RO16 and evaluation of toxicity.
Bedekar, PA; Govindwar, SP; Saratale, GD; Saratale, RG, 2014
)
0.4

Dosage Studied

ExcerptRelevanceReference
" The effects of shaking time, adsorbent dosage and pH on the adsorption capacity were studied."( Application of carbon adsorbents prepared from Brazilian-pine fruit shell for the removal of reactive orange 16 from aqueous solution: Kinetic, equilibrium, and thermodynamic studies.
Calvete, T; Cardoso, NF; Dias, SL; Lima, EC; Pavan, FA; Vaghetti, JC, 2010
)
0.36
" Adsorption experiments were carried out as a function of contact time, concentration of dye, adsorbent dosage and pH using reactive orange 16 as a model pollutant."( Synthesis of porous chitosan-polyaniline/ZnO hybrid composite and application for removal of reactive orange 16 dye.
Kannusamy, P; Sivalingam, T, 2013
)
0.39
" Modeling of column sorption data was performed using the Yoon-Nelson, modified dose-response and Thomas models."( A novel sorbent Ulva lactuca-derived biochar for remediation of Remazol Brilliant Orange 3R in packed column.
Ganesh Prabhu, G; Gokulan, R; Jegan, J, 2019
)
0.75
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (54)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (1.85)18.2507
2000's16 (29.63)29.6817
2010's23 (42.59)24.3611
2020's14 (25.93)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.86

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.86 (24.57)
Research Supply Index4.03 (2.92)
Research Growth Index5.89 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.86)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other55 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]